Repare Therapeutics Inc. — Director's Dealing 2020

Jun 26, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Repare Therapeutics Inc. (RPTX)
CIK: 0001808158
Period of Report: 2020-06-23

Reporting Person: Versant Vantage I, L.P. (10% Owner)
Reporting Person: Versant Vantage I GP, L.P. (10% Owner)
Reporting Person: Versant Vantage I GP-GP, LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-23	Common Shares	C	2054198	—	Acquired	2705660	Indirect
2020-06-23	Common Shares	C	156335	—	Acquired	205915	Indirect
2020-06-23	Common Shares	C	68398	—	Acquired	90090	Indirect
2020-06-23	Common Shares	C	61791	—	Acquired	81387	Indirect
2020-06-23	Common Shares	C	2443883	—	Acquired	2443883	Indirect
2020-06-23	Common Shares	C	111361	—	Acquired	2817021	Indirect
2020-06-23	Common Shares	C	8475	—	Acquired	214390	Indirect
2020-06-23	Common Shares	C	3708	—	Acquired	93798	Indirect
2020-06-23	Common Shares	C	3350	—	Acquired	84737	Indirect
2020-06-23	Common Shares	C	875568	—	Acquired	3319451	Indirect
2020-06-23	Common Shares	C	458282	—	Acquired	458282	Indirect
2020-06-23	Common Shares	P	150000	$20.00	Acquired	608282	Indirect
2020-06-23	Common Shares	P	100000	$20.00	Acquired	3419451	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-23	Class A Preferred Shares	$	C	2054198	Disposed		Common Shares (2054198)	Indirect
2020-06-23	Class A Preferred Shares	$	C	156335	Disposed		Common Shares (156335)	Indirect
2020-06-23	Class A Preferred Shares	$	C	68398	Disposed		Common Shares (68398)	Indirect
2020-06-23	Class A Preferred Shares	$	C	61791	Disposed		Common Shares (61791)	Indirect
2020-06-23	Class A Preferred Shares	$	C	2443883	Disposed		Common Shares (2443883)	Indirect
2020-06-23	Class B Preferred Shares	$	C	111361	Disposed		Common Shares (111361)	Indirect
2020-06-23	Class B Preferred Shares	$	C	8475	Disposed		Common Shares (8475)	Indirect
2020-06-23	Class B Preferred Shares	$	C	3708	Disposed		Common Shares (3708)	Indirect
2020-06-23	Class B Preferred Shares	$	C	3350	Disposed		Common Shares (3350)	Indirect
2020-06-23	Class B Preferred Shares	$	C	875568	Disposed		Common Shares (875568)	Indirect
2020-06-23	Class B Preferred Shares	$	C	458282	Disposed		Common Shares (458282)	Indirect

Footnotes

F1: Each Series A Preferred Share and each Series B Preferred Share converted into the same number of Common Shares upon the closing of the Issuer's initial public offering and had no expiration date.

F2: The securities are held by Versant Venture Capital V, L.P. ("VVC V"). Versant Ventures V, LLC ("VV V") is the sole general partner of VVC V and may be deemed to have voting and investment power over the securities held by VVC V and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial ownership of the shares held by VVC V, except to the extent of its pecuniary interest therein.

F3: The securities are held by Versant Venture Capital V (Canada) LP ("VVC(Canada)"). Versant Ventures V (Canada) GP-GP, Inc. ("VV V (Canada) GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V (Canada)") and VV V (Canada) is the sole general partner of VVC V (Canada). By virtue of such relationships, VV V (Canada) GP and VV V (Canada) may be deemed to have voting and investment power over the securities held by VVC V (Canada) and as a result may be deemed to have beneficial ownership over such securities. Each of VV V (Canada) and VV V (Canada) GP disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of its pecuniary interest therein.

F4: The securities are held by Versant Ophthalmic Affiliates Fund I, L.P. ("VOAF I"). VV V is the sole general partner of VOAF I and may be deemed to have voting and investment power over the securities held by VOAF I and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial ownership of the shares held by VOAF I, except to the extent of its pecuniary interest therein.

F5: The securities are held by Versant Affiliates Fund V, L.P. ("VAF V"). VV V is the sole general partner of VAF V and may be deemed to have voting and investment power over the securities held by VAF V and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial ownership of the shares held by VAF V, except to the extent of its pecuniary interest therein.

F6: The securities are held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. By virtue of such relationships, VV VI GP and VV VI may be deemed to have voting and investment power over the securities held by VVC VI and as a result may be deemed to have beneficial ownership over such securities. Each of VV VI GP and VV VI disclaims beneficial ownership of the shares held by VVC VI, except to the extent of its pecuniary interest therein.

F7: The securities are held by Versant Vantage I, L.P. ("VV I"). Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("VV I GP") and VV I GP is the sole general partner of VV I. By virtue of such relationships, VV I GP and VV I GP-GP may be deemed to have voting and investment power over the securities held by VV I and as a result may be deemed to have beneficial ownership over such securities. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of its pecuniary interest therein.

F8: These securities were purchased by VV I.

F9: These securities were purchased by VVC VI.